Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pharma-Bio Serv (PBSV) Assets Average (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Assets Average for 13 consecutive years, with $13.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average fell 16.47% year-over-year to $13.6 million, compared with a TTM value of $13.6 million through Oct 2025, down 16.47%, and an annual FY2025 reading of $15.0 million, down 17.27% over the prior year.
  • Assets Average was $13.6 million for Q4 2025 at Pharma-Bio Serv, down from $13.7 million in the prior quarter.
  • Across five years, Assets Average topped out at $30.1 million in Q1 2021 and bottomed at $13.6 million in Q4 2025.
  • Average Assets Average over 5 years is $20.5 million, with a median of $20.2 million recorded in 2022.
  • The sharpest move saw Assets Average rose 13.87% in 2021, then dropped 28.33% in 2022.
  • Year by year, Assets Average stood at $26.3 million in 2021, then fell by 21.97% to $20.5 million in 2022, then fell by 1.91% to $20.1 million in 2023, then dropped by 18.88% to $16.3 million in 2024, then dropped by 16.47% to $13.6 million in 2025.
  • Business Quant data shows Assets Average for PBSV at $13.6 million in Q4 2025, $13.7 million in Q3 2025, and $15.0 million in Q2 2025.